|Morningside China TMT Fund I, 2/08||$150M|
Morningside Group is a private investment group founded in 1986 by the Chan family of Hong Kong. The Chan family founded the Hang Lung Group in 1960. Today, the Hang Lung Group consists of Hang Lung Group Limited [0010.HK] and Hang Lung Properties Limited [0101.HK]. Both companies are listed on the Hong Kong Stock Exchange. Hang Lung Properties Limited is a constituent stock of the Hang Seng Index.
Morningside Group invests in private equity and venture capital opportunities in North America, Europe and Asia Pacific. Since 1992, China has increasingly become a significant part of the groupâ€™s investment activities. Morningside Group has investments in the following sectors – machinery manufacturing, high-tech, media, telecommunication, life science, education and cleantech. The group is managed by experienced investment professionals who are entrepreneurial, have deep industry knowledge and are effective in the local environment in which they operate.
In addition to its investment activities, Morningside Group is deeply committed to being socially responsible. Providing access to educational opportunities and supporting scientific research are two major areas of focus for Morningside’s philanthropic endeavors.
|UC Mobile||1/12||Venture Round||kr12M||4|
|Oxyrane UK||11/11||Series D||$26.5M||3|
|Xiaomi Tech||12/10||Venture Round||$35M||2|
|Liquidia Technologies||7/10||Series C||$5M||5|
|eChinaChem Group||6/09||Venture Round||$5M||1|
|HD Biosciences||8/08||Series A||3|
|Plastic Logic||8/08||Series E||$50M||5|
|Inimex Pharmaceuticals||6/08||Series B||$22M||8|
|Traversa Therapeutics||2/08||Series A||$2M||2|
|Altai Technologies||9/06||Venture Round||$10M||2|
|Plastic Logic||11/05||Series C||$24M||4|